Windtree Therapeutics Inc.

09/25/2024 | Press release | Distributed by Public on 09/25/2024 06:45

Windtree Announces Positive Topline Results from Its Phase 2b SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock